These ASX 200 shares could rise 25% to 60%

Brokers are tipping these shares to deliver outsized returns for investors.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are hunting for big returns for your investment portfolio, then look no further than the ASX 200 shares in this article.

That's because analysts are tipping them to rise by 25%+ over the next 12 months. Here's what you need to know about them:

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.

Image source: Getty Images

Flight Centre Travel Group Ltd (ASX: FLT)

The team at Macquarie thinks that this travel agent giant is a cheap ASX 200 share to buy right now.

While it wasn't blown away with its full year results in FY 2025, it believes its valuation is attractive and expects improvements in macro conditions to drive strong performances from its key segments. It said:

Outperform. While profit disappointed, both segments delivered solid TTV growth which should accelerate if macro conditions are more supportive. Valuation is attractive, and we see material upside to the current share price over a 12m view.

Macquarie has an outperform rating and $16.55 price target on Flight Centre's shares. Based on its current share price of $13.03, this implies potential upside of 27% for investors over the next 12 months.

In addition, it is forecasting a fully franked dividend yield of 3% in FY 2026, which boosts the total potential return to 30%.

Telix Pharmaceuticals Ltd (ASX: TLX)

Analysts at Bell Potter think that big returns could be coming for patient investors with this beaten down radiopharmaceuticals company's shares.

Although it concedes that this year has been tough for approvals (most recently the denial of Zircaix by the US FDA), it remains very positive on its longer term outlook and appears to see the recent share price weakness as a buying opportunity. It said:

The previous forecast included modest revenues from Zircaix in FY26 ($31m) which is now stripped out and EBITDA is reduced by $13m. The company does not plan to curtail any R&D spend at this point as it remains well capitalised and we expect will continue to generate cash from operations. This is the second CRL for TLX this calendar year. The delay to revenues and knock on effect to the cost of capital (risk) and valuation are material, accordingly our TP is reduced.

Bell Potter has put a buy rating and $23.00 price target on the ASX 200 share. Based on its current share price of $14.60, this suggests that upside of almost 60% is possible for investors between now and this time next year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group and Telix Pharmaceuticals. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended Flight Centre Travel Group and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Three excited business people cheer around a laptop in the office
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A graphic image of a pile of gold coins balanced precariously with a house on top with smoke coming out of the chimney and a human figure with hands up as if to shield himself from the prospect of the house falling.
Broker Notes

This debt collector could surge 47% on negative gearing changes, Shaw and Partners says

A weaker housing market could be a boon for this company.

Read more »

Three young nerds dressed in suits with thinking caps and lightbulbs
Broker Notes

Brokers name 3 ASX shares to buy right now

Let's find out which shares top brokers are feeling bullish about this week.

Read more »

A woman in a red dress holding up a red graph.
Broker Notes

4 ASX shares Macquarie says could return more than 40%

The broker has made some bold predictions.

Read more »

A woman leans forward with her hand behind her ear, as if trying to hear information.
Broker Notes

Down 60%, are Cochlear shares now a bargain buy?

A leading analyst provides his outlook for Cochlear’s beaten-down shares.

Read more »

A businessman hugs his computer and smiles.
Broker Notes

Why this ASX stock is a 'compelling value play'

Value investors might want to check out this share that Bell Potter is bullish on.

Read more »

Man holding a calculator with Australian dollar notes, symbolising dividends.
Broker Notes

Should I buy Rio Tinto shares for passive income?

A leading analyst provides his outlook for Rio Tinto shares and dividends.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

4 ASX shares upgraded by brokers this week

Brokers have new confidence in TPG Telecom, Deep Yellow, and other stocks this week.

Read more »